reports
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference WINTER SPRINGS, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that it will participate in the 37th Annual Roth Conference. Iradimed’s CFO, Jack Glenn, and CCO, Jeff Chiprin, will host one-on-one meetings between company management and investors at the 37th Annual Roth Conference, which will be held at the Laguna Cliffs Marriott in Dana Point, CA, on March 17 and 18, 2025. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in developing innovati...
Universal Reports Fourth Quarter 2024 Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings (NYSE: UVE) (“Universal” or the “Company”) reported fourth quarter and full year 2024 results. * Reconciliations of GAAP to non-GAAP financial measures are provided in the attached tables. “In 2024, we experienced three hurricanes, including Debbie, Helene and Milton, and we’re working hard, as we always do, to help our customers restore their lives,” said Stephen J. Donaghy, Chief Executive Officer. “We continue to see progress relative to claims trends in our Florida book and recently filed a modest rate decrease in th...
Moelis & Co: 9 directors
Nine Directors at Moelis & Co sold after exercising options/sold 63,137 shares at between 72.300USD and 74.000USD. The significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the co...
Dime Community Bancshares Inc: 1 director
A director at Dime Community Bancshares Inc sold 25,000 shares at 32.691USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Fi...
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share Reports record revenue of $19.4 million for the fourth quarter of 2024, an increase of $1.9 million or 11%, compared to the same period in 2023. Reports GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.44 for the fourth quarter of 2024.Reports GAAP diluted EPS of $1.50 and non-GAAP diluted EPS of $1.66 for the full year of 2024.Declares a regular quarterly cash ...
Universal Announces Fourth Quarter 2024 Earnings Dates
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) will issue a press release reporting its fourth quarter 2024 results after the market closes on Tuesday, February 25, 2025. The company will host a conference call on Wednesday, February 26, 2025, at 10:00 a.m. ET to discuss financial results. Investors and other interested parties may listen to the call by accessing the online, real-time webcast at or by registering in advance via teleconference at . Once registration is completed, participants will be provided with a dial...
Universal Declares Regular Cash Dividend
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) announced today that its Board of Directors has declared a quarterly cash dividend of 16 cents per share of common stock, payable March 14, 2025 to shareholders of record as of the close of business on March 7, 2025. About Universal Universal Insurance Holdings, Inc. (NYSE: UVE) is a holding company providing property and casualty insurance and value-added insurance services. We develop, market, and write insurance products for consumers predominantly in the personal resid...
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024...
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025 WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market opens on Thursday, February 13, 2025. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by register...
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quart...
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 millionReports preliminary full-year 2024 revenue in the range of approximately $73.1 million to $73.3 millionIradimed is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15th, 2025, at 5:15 p.m. PT WINTER SPRINGS, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD), a leader in developing innova...
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthc...
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference WINTER SPRINGS, Fla., Dec. 19, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (“MRI”) compatible medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system announced today that Roger Susi, Chief Executive Officer and Jack Glenn, Chief Financial Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference. The Company presentation will take place on Wednesday, Janua...
Assured Guaranty Ltd: 1 director
A director at Assured Guaranty Ltd sold 34,000 shares at 88.330USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Smal...
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025 WINTER SPRINGS, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), today announced it has been ranked 24th on Forbes’ list of America’s Most Successful Small-Cap Companies 2025. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring systems that are designed for use during MRI ...
Iradimed Corp: 1 director
A director at Iradimed Corp sold 2,500 shares at 54.180USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- MarketLine Department
Glory Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances
Summary Marketline's Glory Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Glory Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer...
Universal Declares Regular and Special Cash Dividends
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) announced today that its Board of Directors has declared a regular quarterly cash dividend of 16 cents per share of common stock and a special cash dividend of 13 cents per share of common stock, together totaling 29 cents per share of common stock, both payable on December 13, 2024 to shareholders of record as of the close of business on December 6, 2024. Today’s announcement brings total dividends declared in 2024 to 77 cents per share of common stock. About Universal Univ...
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies ...
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024 WINTER SPRINGS, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures. “Being recognized by Fortune as o...
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results...
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share Reports record revenue of $18.3 million for the third quarter of 2024, an increase of $1.8 million or 11% over the comparable period 2023.Reports GAAP diluted EPS of $0.40 and Non-GAAP diluted EPS of $0.43 for the third quarter of 2024.Raising year end guidance on GAAP diluted earnings per share to $1.49 to $1.52 from $1.37 to $1.47, and Non-GAAP diluted earnings per share to $1.64 to $1.67 from $1.52 to $1.62. Declares a regular quarterly cash...
Universal Reports Third Quarter 2024 Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings (NYSE: UVE) (“Universal” or the “Company”) reported third quarter 2024 results. *Reconciliations of GAAP to non-GAAP financial measures are provided in the attached tables. “Our hearts and thoughts go out to those impacted by recent disasters, including Hurricanes Debbie and Helene in the third quarter and Hurricane Milton in the fourth quarter,” said Stephen J. Donaghy, Chief Executive Officer. “We’ve been through many hurricanes in our nearly three-decade history, arming us with the requisite experience to quickly and ef...
- MarketLine Department
Glory Ltd - Company Profile and SWOT Analysis
Summary Glory Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Glory Ltd (Glory) develops and manufactures cash handling machines and systems based on its recognition/identification and mechatronics technology. The company's product portfolio includes open teller systems...
Universal Announces Third Quarter 2024 Earnings Release and Conference...
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) will issue a press release reporting its third quarter 2024 results after the market closes on Thursday, October 24, 2024. The company will host a conference call on Friday, October 25, 2024, at 10:00 a.m. ET to discuss financial results. Investors and other interested parties may listen to the call by accessing the online, real-time webcast at or by registering in advance via teleconference at . Once registration is completed, participants will be provided with a dial-in nu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.